The quality of life in MCCPs is significantly lower than that of control mothers. Also, although the BAI scores were not significantly different between the groups, the BDI scores were poorer in MCCPs compared to those the control group.

No abstract

Alkaptonüri; homogentisik asit oksidaz enzim eksikliğine bağlı gelişen nadir görülen otozomal resesif geçen metabolik bir hastalıktır. Alkaptonüri pek çok sistemi etkileyebildiği gibi muskuloskeletal sistemle ilgili olarak omurgada ve periferik eklemlerde dejeneratif değişikliklere neden olur. 53 yaşında kadın hasta progressif artan bel ağrısı ve diz ağrısı nedeniyle çekilen grafilerde spinal ankiloz olması üzerine olası Ankilozan spondilit açısından romatoloji kliniğimize yönlendirilmişti. Fizik muayenesinde kulaklarda, burunda ve tırnaklarda mavimsi siyah renk değişiklikleri görüldü. Spinal grafilerinde disk aralıkları daralmış, disklerde kalsifikasyon ve dejenerasyon, üst lomber vertebralarda füzyon ve sakroiliak eklemlerin açık olduğu görüldü. Bu makalede bel ağrısı ve dizde şişlik şikayeti olan, klinik, radyolojik ve laboratuvar değerlendirmeler sonucunda okronotik spondiloz ve periferik artropati tanısı konulan bir vaka sunulmuş

In order to replenish iron stores and bring hemoglobin (Hb) levels back to normal, oral iron is the primary treatment option for women with iron deficiency anemia (IDA). This study investigated the efficacy and side effects of daily versus alternate-day, given single doses versus double doses oral iron supplementation for treating IDA. A retrospective cohort study was performed between 2021 and 2022, including 120 patients. Study group were divided into 4 age-sex-matched groups; Group I (n = 30) and Group II (n = 30) which were received ferrous sulphate tablets daily in single or double doses, respectively, containing 60 mg of elemental iron each. Groups III (n = 30) and IV (n = 30) were received a single and double dose on alternate days, respectively. The primary outcome was the mean difference in Hb from baseline at week 4. Gastrointestinal (GI) side effects were accepted as a secondary outcome. The daily single dose and alternate day double dose groups had median Hb changes of 2.3 (2.1) and 2.6 (1.8) g/dL. The differences in Hb between Groups I and II, I and III, and Groups IV and II, IV and III were significant (P < .001, P = .001, P < .001, and P < .001, respectively). There is no significant difference between groups regarding improving iron parameters such as serum iron, total iron binding capacity, transferrin saturation, and ferritin. The incidence of GI side effects were greater in double doses than in single doses of daily or alternate-day therapies (43.3% and 30% vs 10% and 3.3%). Daily or alternate-day double dose resulted in more side effects but less therapeutic efficacy in women with IDA. To find the best supplementation method, randomized controlled trials with a larger sample of participants, longer study lengths, and various iron doses may be helpful.

No abstract